ME
NU
Donate

Eliminating Anti-Rejection Drugs

Eliminating anti-rejection drugs for kidney transplant recipients

Northwestern University
Chicago, IL Dr. Joseph Leventhal

At Northwestern University in Chicago, the National Stem Cell Foundation partnered with the U.S. Department of Defense to help fund a collaboration between the Institute for Cellular Therapeutics (ICT) at the University of Louisville and Dr. Joseph Leventhal, Professor of Surgery in the Division of Organ Transplantation at Northwestern University Medical School and Director of the Living Donor Renal Transplant Program at Northwestern Memorial Hospital. This collaboration is using stem cells from a kidney donor to eliminate the need for anti-rejection drugs following a kidney transplant. The research is in active clinical trials.